Alzheimer’s for Amateurs

Research Index entry · Trial

PRI-002, a pill aimed at toxic amyloid clumps, missed its main goal

Evidence
People · mid-stage trial
Source
clinicaltrials.gov
Added
2 October 2026

What it is

PRI-002 is a daily pill from Priavoid designed to break up small toxic clumps of amyloid. In the PRImus-AD trial of 304 people, it didn’t slow decline more than a placebo at 48 weeks.

Where it stands

  1. Lab discovery
  2. Animal studies
  3. First studies in people
  4. Large trials
  5. Approved

A miss in a mid-stage trial. Priavoid will show the full data at meetings in 2027.

Update timeline

What changed

Newest first. Only changes to the subject itself appear here: new information, or something proven wrong.

  1. Watching
    The Scouts look again every Friday

    Only new information or a correction shows up here, not another mention of the same thing.

  2. Update

Research connections

Why these belong together

A connection has to say what it adds. Shared keywords alone don’t count.

Educational, not medical advice. Spot something wrong? hello@alzamateurs.com